Skip to main content
. 2023 Jul 13;280(11):4739–4750. doi: 10.1007/s00405-023-08110-w

Table 3.

Potential biomarkers in salivary gland tumours [11, 14]

Tumour type Gene rearranged or mutated Frequencies Ancillary IHC
Acinic cell carcinoma NR4A3  ~ 85% NR4A3
Adenoid cystic carcinoma MYB 29–86% Myb
NOTCH1  ~ 14% NICD
Mucoepidermoid carcinoma CRTC1 40–90% Areg
Salivary duct carcinoma AR 40–70% AR
ERBB2 (HER2) 29–35% Her2
Secretory carcinoma NTRK (primarily ETV3-NTRK3 fusion)  > 90% Pan-Trk
Basal cell adenoma CTNNB1 37–80% β-Catenin, LEF-1
Pleomorphic adenoma and carcinoma ex pleomorphic adenoma PLAG1  > 50% Plag1
HMGA2 10–20% Hmga2